Table 1.
Patient Characteristics (n = 335) | ||
---|---|---|
Median age (y; range) | 65 (32–88) | |
Country (DE/AT/CH; n = 324) | 156 (48.1%)/130 (40.1%)/38 (11.7%) | |
Gender (male/female; n = 333) | 164 (49.2%)/169 (50.8%) | |
Prior lines of therapy (n = 305) | ||
1 | 70 (23.0%) | |
2–3 | 106 (34.8%) | |
≥4 | 129 (42.3%) | |
Median time (y) since start of first-line therapy (range) | 4.96 (0.04–27.97) | |
ASCT (yes/no; n = 325) | 245 (75.4%)/80 (24.6%) | |
Infections During | 12 mo Before Start of Therapy, n = 322 | 6 mo After Start of Therapy, n = 314 |
None | 155 (48.1%) | 181 (57.6%) |
1–3 | 128 (39.8%) | 125 (39.8%) |
≥4 | 39 (12.1%) | 8 (2.5%) |
ASCT = autologous stem cell transplantation; AT = Austria; CH = Switzerland; DE = Germany.